£76.63

This is the most expensive it has ever been. Walk away.

£77 today · previous high £77 · all-time low £76

Springer Adjuvant Therapy of Breast Cancer V: 140 (Recent Results in Cancer Research, 140)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 74 days · 74 data points (no recent data)

Historical
Generating forecast…
£76.63 £76.40 £76.45 £76.50 £76.55 £76.60 £76.65 22 August 2026 09 September 2026 27 September 2026 15 October 2026 03 November 2026
View at Amazon ↗

Price data last checked 17 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 74 days • 1 price levels

Days at Price
74 days 0 19 37 56 74 £76 Days at Price

Price Analysis

Most common price: £76 (74 days, 100.0%)

Price range: £76 - £76

Price levels: 1 different prices over 74 days

Description

We often hear physicians, health care professionals, poli ticians, and patient advocates that "nothing has happened in the treatment of breast cancer," since patients with breast cancer, the most frequent neoplastic condition in women in industrialized countries, are continuing to suffer relapse and succumb to this dreadful disease! This negativistic attitude does not seem to be justified, but, why is the transmission of clinical trial results into general practice, and with it progress, such a slow process? After many decades of frustrating stagnation of long-term survival expectations, in all stages of early, oper/lble breast cancer treated only by surgery and locoregional radio therapy, adjuvant systemic therapy (chemo- as well as endocrine treatments) clearly showed to significantly benefit in terms of disease-free and overall survival. This evolution has been extensively expounded on by the Worldwide Oxford Overview and the Expert Consensus Panel at the fourth International Conference 'on Adjuvant Therapy of Primary Breast Cancer in St. Gallen (Early Breast Cancer Trialists' Collaborative Group 1992; Glick et al. 1992). What has happened since then? During the past 3-5 years, several new concepts and treatment strategies have emerged and have been studied in various major breast cancer groups and treatment centers worldwide. Some of these can already be considered to assist in the primary treatment of operable breast cancer today, while others are . still undergoing clini,cal trials for better definition of their practical usefulness.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
25 December 2011
Listed Since
13 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)
89% match

Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)

Springer

£149.65 23 Oct 2026
Prognostic variables in node-negative and node-positive breast cancer
85% match

Prognostic variables in node-negative and node-positive breast cancer

Springer

£166.90 23 Oct 2026
A Practical Guide to Breast Cancer Treatment
84% match

A Practical Guide to Breast Cancer Treatment

Springer

£115.72 22 Oct 2026
Breast Cancer: Origins, Detection, and Treatment: Proceedings of the International Breast Cancer Research Conference London, United Kingdom ― March 24–28, 1985: 43 (Developments in Oncology, 43)
84% match

Breast Cancer: Origins, Detection, and Treatment: Proceedings of the International Breast Cancer Research Conference London, United Kingdom ― March 24–28, 1985: 43 (Developments in Oncology, 43)

Springer

£78.17 22 Oct 2026
Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)
83% match

Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)

Springer

£80.67 21 Oct 2026
Breast Cancer Diagnosis
83% match

Breast Cancer Diagnosis

Springer

£76.42 24 Oct 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
83% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£86.76 27 Oct 2026
The Etiology of Human Breast Cancer: Endocrine, Genetic, Viral, Immunologic and Other Considerations
83% match

The Etiology of Human Breast Cancer: Endocrine, Genetic, Viral, Immunologic and Other Considerations

Springer

£78.01 22 Oct 2026
Non-Disseminated Breast Cancer: Controversial Issues in Management (Medical Radiology)
83% match

Non-Disseminated Breast Cancer: Controversial Issues in Management (Medical Radiology)

Springer

£76.42 24 Oct 2026
Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)
82% match

Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)

Springer

£120.78 27 Oct 2026
Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)
82% match

Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)

Springer

£114.43 23 Oct 2026
Endocrine Therapy of Breast Cancer VI (ESO Monographs)
82% match

Endocrine Therapy of Breast Cancer VI (ESO Monographs)

Springer

£76.42 24 Oct 2026
Trends in Breast Cancer Prevention
82% match

Trends in Breast Cancer Prevention

Springer

£76.38 02 Nov 2026
Breast Cancer Risk Reduction and Early Detection
82% match

Breast Cancer Risk Reduction and Early Detection

Springer

£79.70 26 Oct 2026
Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook
82% match

Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook

Springer

£162.32 22 Oct 2026
Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy
82% match

Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy

Springer

£74.21 26 Oct 2026
Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options
82% match

Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options

Springer

£60.47 27 Oct 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
82% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£113.76 29 Oct 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
82% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 22 Oct 2026
Triple-Negative Breast Cancer: A Clinician’s Guide
81% match

Triple-Negative Breast Cancer: A Clinician’s Guide

Springer

£80.67 21 Oct 2026
Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities: 862 (Advances in Experimental Medicine and Biology, 862)
81% match

Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities: 862 (Advances in Experimental Medicine and Biology, 862)

Springer

£78.95 23 Oct 2026
Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)
81% match

Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)

Springer

£113.76 22 Oct 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
81% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£161.26 24 Oct 2026
Approaches to Breast Cancer Prevention: 62 (Developments in Oncology, 62)
81% match

Approaches to Breast Cancer Prevention: 62 (Developments in Oncology, 62)

Springer

£146.35 22 Oct 2026